{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:32:04Z","timestamp":1786437124457,"version":"build-2736575974"},"reference-count":108,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Human papillomavirus (HPV) infection is a necessary but insufficient cause of cervical cancer (CC) and reflects a long-standing host\u2013virus equilibrium shaped by immune control, viral persistence, and latency. The transition from cytology-based screening to primary high-risk HPV testing has substantially improved early detection of cervical precancerous lesions but has also introduced new clinical challenges related to fluctuating test results, overdiagnosis, overtreatment, and patient anxiety, whose magnitude may vary across countries depending on screening organization and access to prevention services. This narrative review provides a clinically oriented overview of HPV-based CC screening in the context of evolving knowledge on HPV natural history, persistence, and immune interaction, and discusses the implications for the interpretation of test results and risk stratification. New emerging screening and triage approaches, including molecular biomarkers, exosome-based biomarkers, and artificial-intelligence-supported risk assessment, are reshaping CC prevention strategies by enabling more precise identification of women at risk for clinically significant disease. These tools may be particularly relevant in self-sampling-based screening pathways, where molecular triage strategies can reduce the need for additional clinician-collected samples and improve management of HPV-positive women. At the same time, improved understanding of viral latency and host-related determinants of progression supports a shift from binary test interpretation toward longitudinal and individualized risk assessment. Integrating biological insight with technological innovation may facilitate personalized screening strategies that maintain high sensitivity while reducing unnecessary interventions. An evolutionary-informed and risk-adapted approach to HPV-related disease management is essential to optimize prevention outcomes and preserve the benefits of population-based screening programs.<\/jats:p>","DOI":"10.3390\/cancers18162576","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:09:36Z","timestamp":1786435776000},"page":"2576","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Impact of HPV Self-Sampling and Molecular Biomarkers on Cervical Cancer Screening and Triage: \u201cThe Times They Are A-Changin\u2019\u201d\u2014A Comprehensive Review and Future Perspectives"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2796-1824","authenticated-orcid":false,"given":"Carlo","family":"Liverani","sequence":"first","affiliation":[{"name":"Gynecology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Boero","sequence":"additional","affiliation":[{"name":"Gynecology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermelinda","family":"Monti","sequence":"additional","affiliation":[{"name":"Gynecology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8761-9839","authenticated-orcid":false,"given":"Carlotta","family":"Caia","sequence":"additional","affiliation":[{"name":"Gynecology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2932-518X","authenticated-orcid":false,"given":"Leonardo","family":"Natalini","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-0996","authenticated-orcid":false,"given":"Paolo","family":"Vercellini","sequence":"additional","affiliation":[{"name":"Academic Center for Research on Adenomyosis and Endometriosis, Department of Clinical Sciences and Community Health, Universit\u00e0 degli Studi di Milano, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-3741","authenticated-orcid":false,"given":"Michele","family":"Vignali","sequence":"additional","affiliation":[{"name":"Gynecology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8037-4947","authenticated-orcid":false,"given":"Andrea","family":"Ciavattini","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.virol.2018.01.002","article-title":"Classification and Evolution of Human Papillomavirus Genome Variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61)","volume":"516","author":"Chen","year":"2018","journal-title":"Virology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pruski, D., Millert-Kali\u0144ska, S., Wszo\u0142ek, K., Musia\u0142owicz, V., Grabowski, J.P., Jach, R., Muallem, M.Z., Sehouli, J., and Przybylski, M. (2026). Analysis of Molecular Markers of HPV Infection Persistence: A Narrative Review. Cancers, 18.","DOI":"10.3390\/cancers18060981"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of Human Papillomavirus Testing on Self-Collected versus Clinician-Collected Samples for the Detection of Cervical Intraepithelial Neoplasia of Grade 2 or Worse: A Randomised, Paired Screen-Positive, Non-Inferiority Trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/LGT.0000000000000885","article-title":"Self-Collected Vaginal Specimens for HPV Testing: Recommendations from the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee","volume":"29","author":"Wentzensen","year":"2025","journal-title":"J. Low. Genit. Tract Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13643-023-02252-y","article-title":"HPV Self-Sampling versus Healthcare Provider Collection on the Effect of Cervical Cancer Screening Uptake and Costs in LMIC: A Systematic Review and Meta-Analysis","volume":"12","author":"Mekuria","year":"2023","journal-title":"Syst. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41591-024-03014-6","article-title":"Cervical Cancer Screening Using DNA Methylation Triage in a Real-World Population","volume":"30","author":"Schreiberhuber","year":"2024","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2016.02.012","article-title":"Validation of the FAM19A4\/Mir124-2 DNA Methylation Test for Both Lavage- and Brush-Based Self-Samples to Detect Cervical (Pre)Cancer in HPV-Positive Women","volume":"141","author":"Verhoef","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cakir, M.O., Selek, M., and Yilmaz, B. (2025). Exosomes in HPV-Associated Cancers: From Biomarkers to Engineered Therapeutics. Cancers, 17.","DOI":"10.3390\/cancers17203386"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gameiro, S.F., and Flondra, K.M. (2023). Human Papillomavirus-Associated Tumor Extracellular Vesicles in HPV+ Tumor Microenvironments. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175668"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2026.05.019","article-title":"Comparative Performance of HPV Self-Sampling and Conventional Screening Methods: A Systematic Review and Bivariate Meta-Analysis","volume":"210","author":"Dixit","year":"2026","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejogrb.2024.02.032","article-title":"Self-Sampling for HPV Testing in Cervical Cancer Screening: A Scoping Review","volume":"296","author":"Colonetti","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Daponte, N., Valasoulis, G., Michail, G., Magaliou, I., Daponte, A.-I., Garas, A., Grivea, I., Bogdanos, D.P., and Daponte, A. (2023). HPV-Based Self-Sampling in Cervical Cancer Screening: An Updated Review of the Current Evidence in the Literature. Cancers, 15.","DOI":"10.3390\/cancers15061669"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","article-title":"Global and Regional Estimates of Genital Human Papillomavirus Prevalence among Men: A Systematic Review and Meta-Analysis","volume":"11","author":"Bruni","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human Papillomavirus Genotype Attribution in Invasive Cervical Cancer: A Retrospective Cross-Sectional Worldwide Study","volume":"11","author":"Quint","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Anwer, M., Bhaliya, K., Zahra, M., Virk, U.Y., Malik, H.A., and Wei, M.Q. (2026). Therapeutic Landscape of HPV-Associated Cancers: From Mechanisms and Conventional Approaches to Future Innovations. Cancers, 18.","DOI":"10.3390\/cancers18040636"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2526683","DOI":"10.1001\/jamanetworkopen.2025.26683","article-title":"Cervical Cancer Screening, HPV Vaccination, and Cervical Cancer Elimination","volume":"8","author":"Luu","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Salvador, S. (2025). HPV Testing, Self-Collection, and Vaccination: A Comprehensive Approach to Cervical Cancer Prevention. Curr. Oncol., 32.","DOI":"10.20944\/preprints202510.0082.v1"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lehtinen, M., Gray, P., Luostarinen, T., Eriksson, T., Apter, D., Bly, A., Harjula, K., Heikkil\u00e4, K., Hokkanen, M., and Kuortti, M. (2024). Head-to-Head Comparison of Two Human Papillomavirus Vaccines for Efficacy against Cervical Intraepithelial Neoplasia Grade 3 and Adenocarcinoma in Situ\u2014Population-Based Follow-up of Two Cluster-Randomized Trials. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1437704"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1056\/NEJMoa2506765","article-title":"Noninferiority of One HPV Vaccine Dose to Two Doses","volume":"393","author":"Kreimer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal Attribution of Human Papillomavirus Genotypes to Invasive Cervical Cancer Worldwide: A Systematic Analysis of the Global Literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e29190","DOI":"10.1002\/jmv.29190","article-title":"Prevalence and Genotype Distribution of Human Papillomavirus in Cervical Adenocarcinoma (Usual Type and Variants): A Systematic Review and Meta-analysis","volume":"95","author":"Reynders","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/AOG.0000000000003761","article-title":"Diagnosis and Management of Adenocarcinoma in Situ","volume":"135","author":"Teoh","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e29685","DOI":"10.1002\/jmv.29685","article-title":"High-risk HPV Oncoproteins E6 and E7 and Their Interplay with the Innate Immune Response: Uncovering Mechanisms of Immune Evasion and Therapeutic Prospects","volume":"96","author":"Calati","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e29191","DOI":"10.1002\/jmv.29191","article-title":"Human Papillomaviruses: Knowns, Mysteries, and Unchartered Territories","volume":"95","author":"Gelbard","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2607594","DOI":"10.1155\/2020\/2607594","article-title":"Perspectives in HPV Secondary Screening and Personalized Therapy Basing on Our Understanding of HPV-Related Carcinogenesis Pathways","volume":"2020","author":"Celewicz","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jamaoncol.2018.4270","article-title":"Five-Year Risk of Cervical Precancer Following P16\/Ki-67 Dual-Stain Triage of HPV-Positive Women","volume":"5","author":"Clarke","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_28","unstructured":"Ryser, M.D., Bravo, I.G., and Campos, N.G. (2025). IPVS Consensus Statement on the Natural History of Cervical HPV Infection. J. Infect. Dis., jiaf574."},{"key":"ref_29","first-page":"219","article-title":"The Role of Colposcopy in HPV Vaccination Era","volume":"77","author":"Natalini","year":"2025","journal-title":"Minerva Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Galani, A., Zikopoulos, A., Moustakli, E., Potiris, A., Paraskevaidi, M., Arkoulis, I., Machairoudias, P., Stavrakaki, S.M., Kyrgiou, M., and Stavros, S. (2025). Cervical Cancer Screening in the HPV-Vaccinated and Digital Era: Reassessing Strategies in Light of Artificial Intelligence and Evolving Risk. Cancers, 17.","DOI":"10.3390\/cancers17193179"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8887672","DOI":"10.1155\/2020\/8887672","article-title":"Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature","volume":"2020","author":"Liverani","year":"2020","journal-title":"J. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00404-013-3011-9","article-title":"The Four Steps in the Prevention of Human Papillomavirus-Associated Neoplasia: Considerations for Preventive Measures, Screening, Disease Impact, and Potential Overtreatments in HPV-Related Pathology","volume":"288","author":"Liverani","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer: Follow-up of Four European Randomised Controlled Trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human Papillomavirus and Cervical Cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"ref_35","unstructured":"Bruni, L., Albero, G., and Serrano, B. (2023). ICO\/IARC Information Centre on HPV and Cancer. Human Papillomavirus and Related Diseases in the World. Summary Report 2023, HPV Information Centre."},{"key":"ref_36","first-page":"1424","article-title":"Risk of Progression of Low-Grade Squamous Intraepithelial Lesions Associated with Oncogenic HPV Infection","volume":"191","author":"Winer","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human Papillomavirus Types among Women Infected with HIV: A Meta-Analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kiamba, E.W., Goodier, M.R., and Clarke, E. (2025). Immune Responses to Human Papillomavirus Infection and Vaccination. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1591297"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez-Rico, D.O., Rizo de la Torre, L.d.C., Zerme\u00f1o-Ruiz, M., Balleza-Alejandri, L.R., Garc\u00eda-Galindo, J.J., Montoya-Fuentes, H., and Beltr\u00e1n-Ram\u00edrez, A. (2026). Bidirectional Interactions Between Cervicovaginal Microbiota and Human Papillomavirus Drive Persistence and Disease Progression. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27125616"},{"key":"ref_40","first-page":"e85880","article-title":"Role of Vaginal and Gut Microbiota in Human Papillomavirus (HPV) Progression and Cervical Cancer: A Systematic Review of Microbial Diversity and Probiotic Interventions","volume":"17","author":"Pai","year":"2025","journal-title":"Cureus"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-22-1927","article-title":"A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I\/IIa Trial","volume":"28","author":"Hillemanns","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1158\/1078-0432.CCR-24-1662","article-title":"Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: A Phase II Trial","volume":"31","author":"Eerkens","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO) (2026, August 04). WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention: Use of Dual-Stain Cytology to Triage Women after a Positive Test for Human Papillomavirus (HPV). Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240091658.","DOI":"10.2471\/B09736"},{"key":"ref_44","unstructured":"World Health Organization (WHO) (2021). WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, World Health Organization. [2nd ed.]."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/LGT.0000000000000788","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023","volume":"28","author":"Perkins","year":"2024","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"ref_47","first-page":"e70041","article-title":"Self-Collected Vaginal Specimens for Human Papillomavirus Testing and Guidance on Screening Exit: An Update to the American Cancer Society Cervical Cancer Screening Guideline","volume":"76","author":"Perkins","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41416-020-0920-9","article-title":"Cervical Screening: ESGO-EFC Position Paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)","volume":"123","author":"Kyrgiou","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_49","first-page":"1","article-title":"Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajog.2025.02.029","article-title":"An Updated Understanding of the Natural History of Cervical Human Papillomavirus Infection-Clinical Implications","volume":"232","author":"Lycke","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ijc.27828","article-title":"Patterns of Persistent Genital Human Papillomavirus Infection among Women Worldwide: A Literature Review and Meta-Analysis","volume":"133","author":"Rositch","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/infdis\/jiq016","article-title":"Prevalence of and Risk Factors for Human Papillomavirus (HPV) Infection among HIV-Seronegative Men Who Have Sex with Men","volume":"203","author":"Goldstone","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural History of Cervical Human Papillomavirus Infection in Young Women: A Longitudinal Cohort Study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ijc.34128","article-title":"Different Human Papillomavirus Types Share Early Natural History Transitions in Immunocompetent Women","volume":"151","author":"Adebamowo","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/infdis\/jiad450","article-title":"Detection and Clearance of Type-Specific and Phylogenetically Related Genital Human Papillomavirus Infections in Young Women in New Heterosexual Relationships","volume":"229","author":"Arthur","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric Outcomes after Conservative Treatment for Intraepithelial or Early Invasive Cervical Lesions: Systematic Review and Meta-Analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bjhp.12612","article-title":"V Exploring the Psychosexual Impact and Disclosure Experiences of Women Testing Positive for High-Risk Cervical Human Papillomavirus","volume":"28","author":"Bennett","year":"2023","journal-title":"Br. J. Health Psychol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ijc.32849","article-title":"Reducing Overtreatment Associated with Overdiagnosis in Cervical Cancer Screening-a Model-Based Benefit-Harm Analysis for Austria","volume":"147","author":"Sroczynski","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/infdis\/jiq116","article-title":"Long-Term Persistence of Prevalently Detected Human Papillomavirus Infections in the Absence of Detectable Cervical Precancer and Cancer","volume":"203","author":"Castle","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/coa.14271","article-title":"Incidence Trends in Head and Neck Cancer Subsites: A National Population-Based Study (2001-2020)","volume":"50","author":"Clements","year":"2025","journal-title":"Clin. Otolaryngol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Meng, X., Yang, B., and Yin, H. (2025). Global Burden and Incidence Trends in Cancers Associated with Human Papillomavirus Infection: A Population-Based Systematic Study. Pathogens, 14.","DOI":"10.3390\/pathogens14090880"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Casta\u00f1eda, K.M., Vermeulen, K.M., van Asselt, A.D.I., Schuuring, E., Wisman, G.B.A., Greuter, M.J.W., and de Bock, G.H. (2025). Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis. Cancers, 17.","DOI":"10.3390\/cancers17040612"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force, Curry, S.J., Krist, A.H., Owens, D.K., Barry, M.J., Caughey, A.B., Davidson, K.W., Doubeni, C.A., Epling, J.W., and Kemper, A.R. (2018). Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 320, 674\u2013686.","DOI":"10.1001\/jama.2018.10897"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer","volume":"356","author":"Kreimer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105149","DOI":"10.1016\/j.ebiom.2024.105149","article-title":"Comparison of HPV-Positive Triage Strategies Combining Extended Genotyping with Cytology or P16\/Ki67 Dual Staining in the Italian NTCC2 Study","volume":"104","author":"Benevolo","year":"2024","journal-title":"EBioMedicine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejogrb.2023.08.369","article-title":"European Consensus Statement on Expert Colposcopy","volume":"290","author":"McGee","year":"2023","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/LGT.0000000000000614","article-title":"The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines","volume":"25","author":"Marcus","year":"2021","journal-title":"J. Low. Genit. Tract Dis."},{"key":"ref_71","unstructured":"Societ\u00e0 Italiana di Colposcopia e Patologia Cervico-Vaginale (SICPCV) (2025). Raccomandazioni SICPCV 2025-2026. Gestione Colposcopica Delle Lesioni Del Basso Tratto Genitale, Edizioni Scientifiche Falco."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jasc.2024.09.003","article-title":"Triage Options for Positive High-Risk HPV Results from HPV-Based Cervical Cancer Screening: A Review of the Potential Alternatives to Papanicolaou Test Cytology","volume":"14","author":"Thrall","year":"2025","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41416-022-01954-9","article-title":"HPV Self-Sampling among Long-Term Non-Attenders to Cervical Cancer Screening in Norway: A Pragmatic Randomised Controlled Trial","volume":"127","author":"Aasbo","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.pmedr.2024.102590","article-title":"Comparison of Diagnostic Accuracy and Acceptability of Self-Sampling Devices for Human Papillomavirus Detection: A Systematic Review","volume":"38","author":"Aimagambetova","year":"2024","journal-title":"Prev. Med. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2468-2667(23)00076-2","article-title":"Effect of HPV Self-Collection Kits on Cervical Cancer Screening Uptake among under-Screened Women from Low-Income US Backgrounds (MBMT-3): A Phase 3, Open-Label, Randomised Controlled Trial","volume":"8","author":"Pretsch","year":"2023","journal-title":"Lancet Public Health"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e2400005","DOI":"10.1200\/GO.24.00005","article-title":"Culturally Competent Education and Human Papillomavirus Self-Sampling Achieves Healthy People 2030 Cervical Screening Target among Low-Income Non-Hispanic Black and Hispanic Women","volume":"10","author":"Shastri","year":"2024","journal-title":"JCO Glob. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary Cervical Cancer Screening with Human Papillomavirus: End of Study Results from the ATHENA Study Using HPV as the First-Line Screening Test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1158\/1055-9965.EPI-24-0655","article-title":"HPV Extended Genotyping to Triage Abnormal Cervical Cancer Screens-Balancing the Harms and Benefits of an Additional Triage Test before Direct Colposcopy Referral","volume":"33","author":"Gottschlich","year":"2024","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e0089724","DOI":"10.1128\/spectrum.00897-24","article-title":"Extended HPV Genotyping by the BD Onclarity Assay: Concordance with Screening HPV-DNA Assays, Triage Biomarkers, and Histopathology in Women from the NTCC2 Study","volume":"13","author":"Bisanzi","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_80","first-page":"22","article-title":"Clinical Significance of Extended High-Risk Human Papillomavirus Genotyping and Viral Load in Cervical Cancer and Precancerous Lesions","volume":"3","author":"Su","year":"2023","journal-title":"Gynecol. Oncol. Case Rep. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ijc.33250","article-title":"Dual Staining for P16\/Ki-67 to Detect High-Grade Cervical Lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing Study","volume":"148","author":"Gotlieb","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ijc.35353","article-title":"P16\/Ki-67 Dual Stain Triage of Individuals Positive for HPV to Detect Cervical Precancerous Lesions","volume":"156","author":"Harper","year":"2025","journal-title":"Int. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e29271","DOI":"10.1002\/jmv.29271","article-title":"P16\/Ki67 Dual Stain Triage versus Cytology in Primary Human Papillomavirus-Based Cervical Cancer Screening with Limited Genotyping","volume":"95","author":"Trzeszcz","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamainternmed.2019.0306","article-title":"Clinical Evaluation of Human Papillomavirus Screening with P16\/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program","volume":"179","author":"Wentzensen","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Del Pino, M., Sierra, A., and Marimon, L. (2019). CADM1, MAL, and MiR124 Promoter Methylation as Biomarkers of Transforming Cervical Intraepithelial Lesions. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092262"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181c7fe6e","article-title":"Quantitative Analysis of Methylation Status of the PAX1 Gene for Detection of Cervical Cancer","volume":"20","author":"Huang","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","article-title":"Performance of DNA Methylation Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia (CIN2+): A Systematic Review and Meta-Analysis","volume":"121","author":"Kelly","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ijc.25890","article-title":"Combined CADM1 and MAL Promoter Methylation Analysis to Detect (Pre-)Malignant Cervical Lesions in High-Risk HPV-Positive Women","volume":"129","author":"Overmeer","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.cmi.2020.03.018","article-title":"FAM19A4\/MiR124-2 Methylation Analysis as a Triage Test for HPV-Positive Women: Cross-Sectional and Longitudinal Data from a Dutch Screening Cohort","volume":"27","author":"Vink","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e20240043","DOI":"10.1002\/INMD.20240043","article-title":"Research Progress of DNA Methylation in the Screening of Cervical Cancer and Precancerous Lesions","volume":"3","author":"Wang","year":"2025","journal-title":"Interdiscip. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.33320","article-title":"Methylation Markers FAM19A4 and MiR124-2 as Triage Strategy for Primary Human Papillomavirus Screen Positive Women: A Large European Multicenter Study","volume":"148","author":"Bonde","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncy.22572","article-title":"Cytology Interpretation after a Change to HPV Testing in Primary Cervical Screening: Observational Study from the English Pilot","volume":"130","author":"Rebolj","year":"2022","journal-title":"Cancer Cytopathol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"116917","DOI":"10.1016\/j.diagmicrobio.2025.116917","article-title":"Methylation Testing versus Cervical Cytology for Triage of HPV-Positive Women: A Comparative Study","volume":"113","author":"Wang","year":"2025","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-Mediated Transfer of MRNAs and MicroRNAs Is a Novel Mechanism of Genetic Exchange between Cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12964-023-01142-z","article-title":"Physiological and Pathological Consequences of Exosomes at the Blood-Brain-Barrier Interface","volume":"21","author":"Salimi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41423-025-01323-5","article-title":"The Role of Exosomes in Immunopathology and Potential Therapeutic Implications","volume":"22","author":"Wang","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Owecki, W., Wojtowicz, K., and Nijakowski, K. (2025). Salivary Extracellular Vesicles in Detection of Cancers Other than Head and Neck: A Systematic Review. Cells, 14.","DOI":"10.3390\/cells14060411"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Di Bonito, P., Accardi, L., and Galati, L. (2019). Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes. Cancers, 11.","DOI":"10.3390\/cancers11020138"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"152188","DOI":"10.1016\/j.bbrc.2025.152188","article-title":"Proteomic and Transcriptomic Profiling in Exosomes Derived from HPV-Positive Head and Neck Cancer","volume":"776","author":"Qin","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5483\/BMBRep.2022.55.9.042","article-title":"Untold Story of Human Cervical Cancers: HPV-Negative Cervical Cancer","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/jnci\/djaf054","article-title":"Initial Evaluation of a New Cervical Screening Strategy Combining Human Papillomavirus Genotyping and Automated Visual Evaluation: The Human Papillomavirus-Automated Visual Evaluation Consortium","volume":"117","author":"Befano","year":"2025","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Farzaneh, F., Soltani, A., and Dastyar, F. (2025). AI-Driven Predictive Modeling of Cervical Intraepithelial Neoplasia Severity: A Comprehensive Analysis with Clinical Adoption Frameworks. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14974-4"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Harsono, A.B., Susiarno, H., and Suardi, D. (2022). Cervical Pre-Cancerous Lesion Detection: Development of Smartphone-Based VIA Application Using Artificial Intelligence. BMC Res. Notes, 15.","DOI":"10.1186\/s13104-022-06250-6"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"102121","DOI":"10.1016\/j.tranon.2024.102121","article-title":"A Comprehensive Review on Recent Advances in Exosome Isolation and Characterization: Toward Clinical Applications","volume":"50","author":"Dilsiz","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.7150\/thno.113650","article-title":"Exosomes: Innovative Biomarkers Leading the Charge in Non-Invasive Cancer Diagnostics","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Jurczak, M., Charzewski, \u0141., Go\u017ali\u0144ska, B., Albrycht, P., Kobus, K., Ludwin, A., Jabiry-Zieniewicz, Z., Kominek, S., Basi\u0144ski, G., and Korzeb, B. (2026). Artificial Intelligence-Assisted Colposcopy: Deep Learning Multi-Class Segmentation of Anatomical Structures and Pathological Findings for Cervical Cancer Screening. Cancers, 18.","DOI":"10.3390\/cancers18091485"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"102992","DOI":"10.1016\/j.eclinm.2024.102992","article-title":"Performance of Artificial Intelligence for Diagnosing Cervical Intraepithelial Neoplasia and Cervical Cancer: A Systematic Review and Meta-Analysis","volume":"80","author":"Liu","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1038\/s41467-024-48705-3","article-title":"Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2576\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:26:31Z","timestamp":1786436791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":108,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162576"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162576","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}